Sir Richard Roberts, winner of the 1993 Nobel Prize in Physiology or Medicine, serves on InVivo’s Board of Directors and InVivo’s Scientific Advisory Board. As a Director, Dr. Roberts is also a member of the Compensation Committee, and a member of the Nominating and Corporate Governance Committee. He is the Chief Scientific Officer at New England Biolabs. Sir Richard’s current research interests focus on using bioinformatics and genomics to find new enzyme activities and to drive his experimental program. Most recently, he is involved in a large community-based project called COMBREX aimed at improving the functional annotation of genomes. He has also worked at Cold Spring Harbor Laboratory, reaching the position of Assistant Director for Research under Dr. J.D. Watson. Sir Richard has also been involved in studies of Adenovirus-2, beginning with studies of transcription that led to the discovery of split genes and mRNA splicing, followed by efforts to deduce the DNA sequence of the Adenovirus-2 genome; a complete sequence of 35,937 nucleotides was obtained. The field of DNA methyltransferases is also an area of active research interest. Sir Richard won the 1993 Nobel Prize in Physiology or Medicine for the discovery of split genes, which opened the door to new insights into therapeutic development and human evolution. Sir Richard holds his B.Sc. in chemistry and Ph.D. in organic chemistry from University of Sheffield. His postdoctoral research was carried out in Professor J.L. Strominger’s laboratory at Harvard, where he studied the tRNAs that are involved in the biosynthesis of bacterial cell walls.